3675
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(865,444) Views
Editor in Chief Professor Garry Walsh
The controversy surrounding OxyContin abuse: issues and solutionsSujata S Jayawant, Rajesh Balkrishnan
The role of measuring airway hyperresponsiveness and inflammatory biomarkers in asthma
Graeme P Currie, Tom C Fardon, Daniel KC Lee
A review of studies of adherence with antihypertensive drugs using prescription databases
Nicola Fitz-Simon, Kathleen Bennett, John Feely
Paclitaxel chemotherapy: from empiricism to a mechanism-based formulation strategy
Charity D Scripture, William D Figg, Alex Sparreboom
Risk factors of allergic rhinitis: genetic or environmental?
De-Yun Wang
The linkage between Churg-Strauss syndrome and leukotriene receptor antagonists: fact or fiction?
Deanna L McDanel, Barbara A Muller
Renal replacement therapy in the intensive care unit
Neesh Pannu, RT Noel Gibney
Clinical implications of changes in hepatic drug metabolism in older people
Sarah N Hilmer, Gillian M Shenfield, David G Le Couteur
Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence
David RP Guay
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Journal Indexing
See where all the Dove Press journals are indexed
